Endo Pharmaceuticals Acquires BioSpecifics Technologies
Endo Pharmaceuticals acquired BioSpecifics Technologies for $658.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Endo Pharmaceuticals
- Acquired Company
- BioSpecifics Technologies
- Price
- $658.0M
- Acquisition Type
- Acquisition
- Announced
- October 19, 2020
Canonical: https://fsome.com/acquisitions/endo-pharmaceuticals-acquires-biospecifics-technologies-8167561 · For the full deal terms, timeline, and press references, please enable JavaScript.